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Mesoporous silica nanoparticles (MSNs) have raised considerable interest as 
vehicles for drug delivery because of their capacity to encapsulate large amounts of 
bioactive species and the ease with which their surface can be chemically modified.[1, 2]  
The versatile chemistry of MSNs has enabled their functionalization with several groups 
to render a variety of gated nanodevices, capable of controlling the loading and release of 
guest molecules in a stimuli-responsive fashion.[3-17]  MSNs are readily endocytosed by 
animal and plant cells,[18-20] and their nanopatterned surface has proven to have a 
significant impact in their biocompatibility.[21, 22]  All these properties have enabled the 
successful application of these materials to the delivery of drugs, genes and proteins into 
living cells, and more recently, into animal models of cancer.[1, 2, 8-10, 23-27]  Since MSNs 
are readily taken up by a wide variety of cell types,[18-20] their use as vehicles for cell 
type-specific intracellular drug delivery might be conditioned to the incorporation of cell-
targeting moieties.[28, 29]  Cellular uptake, however, is not the only factor determining the 
selectivity of a drug delivery system: the relative abilities of the host cells to retain the 
nanoparticles also decide their ultimate fate.  Herein we report an investigation on the 
relative abilities of healthy and cancerous cells to retain endocytosed MSNs, with the 
goal of further understanding the enhanced permeability and retention of nanoparticles 
recently observed in murine models of cancer.[27, 30, 44]  In addition, the incorporation of 
magnetic nanoparticles into porous materials has been recently shown to enable their 
retrieval from liquid media.[31-33]  Combining this with the known ability of MSNs to 
adsorb proteins,[34, 35] we explore the possibility of using the exocytosis of magnetically 
doped MSNs as a means for harvesting intracellular species.   
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 Even if the in vitro endocytosis and the in vivo administration of MSNs have been 
systematically investigated, it is surprising to realize there are no studies on the 
exocytosis or cellular transport of these particles.  This lack of reports could be related to 
the idea that MSNs may be too large for the cells to handle.  In fact, a size retention 
factor has been recently suggested to account for the cellular withholding of aggregates 
of gold nanoparticles.[36, 37]  However, even if MSNs are relatively large, their cellular 
uptake has been repeatedly proven to be energy-dependent, which suggests that cells 
employ their machinery to take these particles up.[20, 29, 38] 
In contrast to MSNs, the exocytosis of non-porous nanoparticles has been studied 
several times.  Most of the reports on the exocytosis of nanoparticles have been based on 
two main approaches: microscopic tracking, and measurement of intra- and extra-cellular 
particle concentrations.[36, 37, 39-43]  These measurements have allowed the use of kinetic 
models to understand the dynamics of nanoparticle endo- and exocytosis.[40]  Following 
these investigations, this study explores some of the consequences of nanoparticle 
exocytosis.  On one hand it describes the role of exocytosis as a potential contributor to 
the enhanced permeability and retention of nanoparticles by cancer cells, which is known 
to take place mainly through hypervasculature,[27, 30, 44] and on the other it shows how the 
exocytosis of highly adsorbing nanoparticles can be used to harvest intracellular 
molecules.  These new results place nanoparticle exocytosis in a context, demonstrating it 
is not only an interesting phenomenon, but it also plays an important role in biological 
processes, and has the potential to lead to valuable biotechnological applications. 
Before investigating the processes resulting from the exocytosis of MSNs, it was 
necessary to establish the timeframe in which the ejection of the particles was most likely 
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to occur.  To do so, we studied the uptake of fluorescein isothiocyanate-labeled MSNs 
(FITC-MSNs) by human umbilical vein endothelial cells (HUVECs) over time.  These 
cells were chosen as models of healthy cells that surround diseased tissue in cancer.  The 
cells were incubated in presence of the particles for increasing periods of time.  The 
intracellular levels of FITC-MSNs were then monitored by flow cytometry, using the 
trypan blue exclusion method for quenching the fluorescence of extracellular particles.[45]  
The average fluorescence intensities of the cells suggested that the amounts of 
endocytosed FITC-MSNs increased gradually with time until reaching a plateau at 
approximately 2 h of contact (Figure 1a).  This plateau can be considered as a state of 
equilibrium between the rates of endo- and exocytosis of the nanoparticles.[40] A similar 
behavior was observed when FITC-MSNs were incubated with human cervical cancer 
cells (HeLa) over the same period of time (Figure 1b). 
Based on these results we proceeded to follow the exocytosis of FITC-MSNs from 
particle-saturated cells under fluorescence confocal microscope.  After incubating 
HUVECs for 3 h in presence of FITC-MSNs, the particles were observed within the cell 
body at the same focal plane as the cell nucleus.  Upon replenishing the culture with fresh 
media at 37°C, the exocytosis of FITC-MSNs was observed within 40 min.  As can be 
observed in the upper set of frames of Figure 2, the fluorescent particles were initially 
co-localized with the cell body.  During the first 15 to 20 min, the particles migrated 
gradually to the boundary of the cell membrane defining the shape of the cell (central set 
of frames).  After some 40 min (lower set of frames of Figure 2) the labeled 
nanoparticles were found mainly in the extracellular space, demonstrating an active 
process of particle discharge. Interestingly, no exocytosis of FITC-MSNs was evident 
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when performing the same experiment with HeLa cells.  Consistent with previous 
observations, endocytosis of the particles was less efficient when the cell growth medium 
contained serum than when it was free of serum.[46]  Conversely, the presence of serum in 
the medium favored exocytosis, as previously reported for other nanoparticles.[42] 
Based on these results we considered the possibility that MSNs exocytosed from 
one cell could be taken up by a neighboring cell.  To evaluate this hypothesis we 
performed a series of cross-cell experiments (Scheme 1).  In the first experiment, two 
cultures of HeLa cells were incubated for 3 h with fluorescently labeled MSNs: one using 
fluorescein isothiocyanate (FITC) and the other one using tetramethyl rhodamine 
isothiocyanate (TRITC) as a label.  The cells were then washed with PBS, harvested by 
trypsinization, mixed and co-incubated for 20 h with serum-containing media at 37°C 
under 5.5% CO2.  The mixed cells were then washed, harvested and analyzed by flow 
cytometry.  After setting gates using unlabeled cells, cells only loaded with FITC-MSNs, 
and cells only loaded with TRITC-MSNs as controls, it was possible to estimate that only 
a small fraction (12.6% ±1.6%) of the cells were FITC and TRITC positive (Figure 3a).  
We considered this result as a measure of the ability of the cells to exchange particles 
between each other.  Examination under confocal microscope showed that indeed, the 
amount of double-labeled cells was very low (Figure 3c).  When the same experiment 
was performed with HUVECs we observed a surprisingly large proportion of particle 
transfer between the cells containing FITC-MSNs and the ones containing TRITC-MSNs.  
The degree of transfer (89.6% ± 1.2%, Figure 3b) was seven times larger than the one 
observed with HeLa cells.  Interestingly, the flow cytometry analysis of the mixture of 
HUVECs showed that instead of a single population with homogeneously distributed 
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amounts of both labeled MSNs, two different populations could be clearly identified: one 
having more FITC-MSNs than TRITC-MSNs, and another one with more TRITC-MSNs 
than FITC-MSNs.  This high efficiency of intercellular MSN transfer in HUVECs was 
further confirmed by confocal fluorescence microscopy (Figure 3d). 
We were further interested in determining if the observed differences between the 
MSN-transfer capabilities of HUVECs and HeLa cells could have implications in the 
distribution of MSNs in a co-culture of both types of cells.  For that purpose we chose to 
label one cell type with a long-term cell tracer dye (Cell Trace™ Far Red DDAO-SE, 
Invitrogen) and treat the other cell type with FITC-MSNs.   Since the cell tracer is not 
exchanged from cell to cell, it was possible to distinguish one cell type from the other 
throughout the experiment.  As can be observed in Figure 4a, when HUVECs were 
stained with the tracer dye and HeLa cells were loaded with FITC-MSNs, very little 
particle transfer (7.5% ± 2.4%) could be observed.  To the contrary, when HeLa cells 
were labeled with the tracer and HUVECs were loaded with the FITC-MSNs, the co-
incubation of both cell types led to a large (74% ± 2.4%) amount of particle transfer 
(Figure 4b).  It could be noted that, after transferring the FITC-MSNs to the HeLa cells, 
the fluorescence intensity of the HUVECs decreased, going from a relatively 
homogeneous distributed population (left plot) to a much wider distribution (right plot). 
These results suggest a unidirectional flow in the nanoparticle transfer between the two 
types of cell, which is consistent with the enhanced permeability and retention recently 
observed for porous silicon and silica nanoparticles in murine models of cancer.[27, 44] 
It has been recently demonstrated that functionalized MSNs are able to capture 
nucleic acids inside of living cells.[47]  Based on this observation, we hypothesized that 
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any endocytosed MSN should be able to sequester molecules found in its intracellular 
stage and keep them once exocytosed.  Being that the case, it should be possible to detect 
the sequestered species by extraction from the recovered MSNs. Considering that MSNs 
are able to reversibly adsorb proteins,[48, 49] we decided to analyze the exocytosed 
nanoparticles in search of cellular proteins. To avoid any interference caused by proteins 
in the growth medium, we performed the exocytosis experiments in serum-free medium.  
MSNs with 10 nm wide pores were chosen to improve the adsorption of proteins (Figure 
5a). To facilitate the isolation of the particles after exocytosis, we prepared 
superparamagnetic iron oxide nanoparticles in the interior of the pores of MSNs (Figure 
5a), following a reported procedure.[50]  Suspensions of magnetic-MSNs in serum-free 
medium (50 g cm-3) were added to cultures of HUVECs that were previously washed 
three times with serum-free medium.   The cells were then incubated for different times 
ranging from 15 min to 4 h at 37°C and 5.5% CO2.  After the specific times, the 
supernatant was removed and transferred to another flask where the particles were 
isolated by means of a magnet and washed three times with PBS.  The recovered 
magnetic-MSNs were then examined by transmission electron microscopy.  The particles 
displayed several areas of low contrast material at their surface, and their pore structure 
was no longer visible (Figure 5b).  These observations suggested the adsorption of 
organic molecules, possibly including proteins, to the particles.  Thermogravimetric 
analysis showed that the percent of organic species adsorbed to the recovered MSNs 
increased with time up to a maximum of 6.5% after 4 h of incubation (Figure 5c). A 
sample of MSNs recovered after 4 h of incubation with HUVECs was then suspended in 
a solution of 10% glycerol, 5% 2-mercaptoethanol and 2% sodium dodecylsulfate, and 
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shaken overnight.  Polyacrylamide electrophoretic analysis of the extract gave four bands 
(Figure 5d), which were later isolated, digested with trypsin, and subjected to tandem 
mass spectrometry analysis. A Mascot search of the resulting mass fingerprints in the 
MSDB, NCBInr and SwissProt databases identified sequences homologous to three 
proteins (p<0.05) for three of the four bands analyzed (Table 1).[51-54]  The matching 
proteins, α-actinin-4, cytoplasmic actin-1 and annexin A2 are all associated with 
membrane and vesicular trafficking events. α-actinin-4 is an F-actin cross-linking protein 
that participates in receptor recycling and in the binding of actin to intracellular 
structures.[55, 56]  Cytoplasmic actin is the main component of cytoskeleton and 
participates in intracellular transport.[57]  Annexin A2 has been reported to link membrane 
phospholipids to actin and to play a key role in exocytosis.[58]  These results strongly 
suggest that the particles were indeed endocytosed, adsorbed proteins at their intracellular 
stage, and were then exocytosed along with their cargoes.  Furthermore, the observed 
association with actin is consistent with a recent report on the strong and dynamic 
interaction between submicron silica particles and the actin present in alveolar 
microvilli.[59] 
In conclusion, the results obtained from the studies on the dynamics of cellular 
uptake of MSNs, cross-cell experiments, and protein sequestration by magnetic MSNs 
are all consistent with the hypothesis that mammalian cells can exocytose MSNs despite 
their relatively large size.  We have demonstrated for the first time not only that 
exocytosis of MSNs takes place, but that there are significant differences between the 
abilities of different cells to retain or expel these nanoparticles, which lead to asymmetric 
cell-to-cell transfer of MSNs.  We were also able to show that, due to their adsorptive 
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properties, MSNs have the ability to sequester and retrieve intracellular molecules.  This 
ability could allow the future use of MSNs either as reporters of cellular processes or as 
nano-harvesters of cell-produced molecules. 
 
 
Experimental Section 
Synthesis of MSNs: MSNs were prepared by our previously reported method.[4]  In brief, 
cetyltrimethylammonium bromide (CTAB, 1.02 g, 2.66 mmol) was dissolved in water 
(480 cm3), followed by the addition of sodium hydroxide solution (2 M, 3.5 cm3). The 
mixture was heated to 80 ºC with vigorous stirring, and then tetraethylorthosilicate (5.0 
cm3, 21.9 mmol) was added drop wise.  The reaction mixture was stirred at this 
temperature for 2 h.  The resulting solid was filtered, washed thoroughly with water and 
methanol and dried under vacuum for 20 h.  The CTAB surfactant was removed by 
refluxing the material (1 g) in methanolic HCl (0.37 %, 100 cm3).  Fluorescent labeling 
was performed by reacting either fluorescein isothiocyanate (FITC) or tetramethyl 
rhodamine isothiocyanate (TRITC) with (3-aminopropyl)trimethoxysilane (APTMS) for 
2 h in anhydrous dimethyl sulfoxide, and adding the resulting product to the initial CTAB 
reaction mixture.  The products were characterized by x-ray diffraction in a Rigaku 
Ultima IV diffractometer, by nitrogen sorption analysis in a micromeritics tristar surface 
area and porosity analyzer using Brunauer-Emmett-Teller equation to calculate apparent 
surface area and pore volume and the Barret-Joyner-Halenda method to calculate pore 
size distribution, and by transmission electron microscopy of samples supported on 
copper grids in a Tecnai G2 F20 microscope operated at 200 kV. 
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Cellular uptake and exocytosis studies:  Cells were seeded in six-well plates and 
incubated at 37°C under 5.5% CO2 in the corresponding growth media (F-12K 
supplemented with heparin, endothelial growth factor and fetal bovine serum for 
HUVEC, and DMEM supplemented with penicillin, streptomycin, gentamicin, alanyl-
glutamine and equine serum for HeLa).  After 24 h incubation the growth media were 
replaced by suspensions of FITC-MSNs (50 and 100 g cm-3) in the corresponding 
growth media, and the cells were incubated for specific times (see main text).  The 
suspensions were then discarded, the cells were harvested by trypsinization and 
resuspended in trypan blue solution for flow cytometry analysis.  Flow cytometry was 
performed in a BD FACSCanto instrument.  For confocal microscopy, glass cover slips 
were set in the bottom of the wells of the plates followed by addition of the cells.  After 
cell attachment, the cells were incubated with FITC-MSNs for periods of time ranging 
from 1 to 4 h, the nuclei were then stained with Hoechst 33258 (blue) dye.  The cells 
were imaged in a Leica SP5 X confocal system with Leica AFS Lite 2.1.0 imaging 
processing software under an oil-immersion 100x objective.  For monitoring exocytosis 
the cells were not fixed and they were imaged using a heated stage (37 °C). 
Synthesis of Magnetic MSNs:  Large pore MSNs were prepared by modifying a literature 
procedure.[60]  Pluronic P104 (courtesy of BASF, 7.0 g) was dissolved in a mixture of 
water (164 g) and aqueous HCl (4 M, 109 g) and kept stirring at 55 °C for 1 h. 
Tetramethyl orthosilicate (10.64 g) was quickly added into the solution at 55 °C.  After 
continuous stirring for 24 h, the reaction mixture was moved to a teflon-lined, high-
pressure autoclave for further hydrothermal treatment at 150 °C for 24 h. The product 
was isolated by filtration, washed with copious water and methanol, and dried at 80 °C in 
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air.  The Pluronic P104 surfactant was removed from MSNs by calcination at 550 °C for 
6 h.  Magnetic MSNs were prepared following a literature procedure,[50] by adding a 
solution of Iron(III) nitrate in ethanol (1.26 g in 10 cm-3) to large pore MSNs (0.5 g). The 
suspension was left to dry in air at 30 °C with constant stirring. The solid was then 
calcined in air at a heating rate of 10 °C min-1 to 300 °C. The resulting brownish powder 
was reduced by calcination in a constant flow of H2 (1.67 cm3 s-1) at 300 °C for 5 h to 
give the resulting magnetic MSNs. 
Cross-cell experiments: For each experiment two groups of cells (either both HUVEC or 
HeLa, or one HUVEC and the other one HeLa) were seeded in T-25 flasks and incubated 
for 24 h at 37°C and 5.5% CO2.  The growth medium was removed from each flask and 
replaced with a suspension of the labeled MSNs in growth media (FITC-MSNs in one 
flask, and TRITC-MSN or Cell Trace™ Far Red DDAO-SE from Invitrogen in the 
other), and incubated under the same conditions for further 3 h.  The cells in each flask 
were then harvested by trypsinization and transferred into 6-well plates with fresh media 
(3 cm-3).  The cells were distributed in the wells in the following way: 3 wells with 
unlabeled cells, 3 wells with cells previously treated with FITC-MSNs, 3 wells with cells 
previously exposed either to TRITC-MSNs or Cell Trace dye (depending on the 
experiment), and 3 wells with a mixed suspension of the cells previously exposed to 
FITC-MSNs and the cells previously exposed to TRITC-MSNs or Cell Trace dye.  The 
cells were incubated for further 20 hours at 37°C and 5.5% CO2 and then harvested by 
trypsinization for flow cytometry analysis. 
In addition, a well containing a cover slip in the bottom was also filled with the mixture 
of the cells exposed to FITC-MSNs and cells exposed to TRITC-MSNs and incubated 
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under the abovementioned conditions.  After 24 h, the cells attached to the cover slips 
were treated with the nuclear stain Hoechst 33258, followed by fixation with 3.7% 
formaldehyde.  Then the cells in the cover slips where mounted on microscope slides and 
imaged under a Leica SP5 X fluorescence confocal microscope with Leica AFS Lite 
2.1.0 imaging processing software. 
Protein sequestration study:  HUVECs were seeded and incubated in T-75 flasks in the 
corresponding growth media for 2 to 3 days to attain the highest cell density possible.  
The media was then replaced by a suspension of magnetic MSNs in serum-free growth 
media (50 g cm-3, 50 cm3) and incubated at 37°C and 5.5% CO2 for specific times 
ranging from 15 min to 4 h.  The flasks were then gently shaken and the supernatant was 
transferred to T-25 flasks with a one-inch diameter neodymium magnet taped to the 
exterior of a wall.  After shaking the flasks the liquid was removed, and the magnet-
immobilized particles were washed thrice with sterile phosphate buffered solution.  For 
protein electrophoresis the particles were then suspended in a tris buffered solution (250 
mm3, 62 mM, pH 6.8) containing 10% glycerol, 5% 2-mercaptoethanol and 2% sodium 
dodecylsulfate, and shaken overnight at room temperature.  The suspension was then 
heated to 95°C for 5 min and aliquots (30 mm3) were loaded into the wells of a Tris-HCl 
polyacrylamide precast gel (10-20%, 10 wells, 50 mm3 per well, Bio-Rad laboratories) 
and subjected to electrophoresis at 135 V for 75 min.  The resulting gels were stained 
with coomassie-blue, destained with acetic-acid methanol and photographed. The 
resulting bands were cut from the gel, digested in trypsin and subjected to MALDI 
MS/MS analysis.  The resulting MS/MS data were used to perform a database search 
using Mascot software.[51]  For quantification of organics the recovered particles were 
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dried overnight under vacuum, and then subjected to thermogravimetric analysis in a TA 
Instruments 2950 Analyzer in air under atmospheric pressure.  The heating rate was 2°C 
min-1 from 25°C to 650°C. 
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Scheme 1. Cross-cell experiments.  Two cultures of cells were incubated separately, each 
with different labeled MSNs (FITC-MSNs one, TRITC-MSNs the other one).  After 
uptake of the particles each culture was washed and harvested.  Both cultures were then 
mixed and co-incubated to evaluate nanoparticle transfer between each other. 
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Figure 1. Changes in average fluorescence intensity of HUVEC (a) and HeLa (b) cells 
when incubated with suspensions of FITC-MSNs for different times. (Sample size N = 3). 
0
20
40
60
80
100
120
0 1 2 3 4
N
or
m
al
ize
d 
Av
er
ag
e 
In
te
ns
ity
Time/h
0
20
40
60
80
100
120
0 1 2 3 4
N
or
m
al
ize
d 
Av
er
ag
e 
In
te
ns
ity
Time/h
Submitted to  
 
 - 20 - 
 
 
 
Figure 2. Laser fluorescence confocal micrographs of HUVECs pre-incubated with 
FITC-MSNs (green spots) after 0 (top), 13 (middle) and 37 (bottom) minutes of addition 
of fresh growth medium.  The images to the left correspond to the FITC channel, and the 
ones to the right correspond to the overlay of the FITC channel with the corresponding 
phase contrast images.  The images show the migration of the nanoparticles from the 
interior of the cells to the periphery and eventually to the intercellular space with time.  
(Scale bar is 25 μm) 
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Figure 3. Dot plots from the flow cytometry analysis of the cross-cell experiments using 
HeLa cells (a) and HUVECs (b).  The axes correspond to the intensity of green 
fluorescence due to uptake of FITC-MSNs (vertical axis) and of red fluorescence due to 
uptake of TRITC-MSNs (horizontal axis). FITC-fluorescent cells appear in area Q1, 
TRITC-fluorescent cells in area Q4, and cells with both fluorescent signals appear in area 
Q2, cells in area Q3 were FITC- and TRITC-negative as determined by a control 
involving non-labeled cells.  Plots at the left correspond to the cells exposed only to 
FITC-MSNs, center plots correspond to the cells exposed only to TRITC-MSNs, and 
plots at the right correspond to the co-incubated cells (cross-cell experiment).  Confocal 
fluorescence images of HeLa cells (c) and HUVECs (d) resulting from the cross-cell 
experiments.  The channels from left to right correspond to cell nuclei stained with 
Hoechst 33258, FITC-MSNs, TRITC-MSNs and the merge of all images. 
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Figure 4. Cross-cell experiments between different cell types. In experiment (a) 
HUVECs were stained with red fluorescent cell tracer, and HeLa cells were incubated 
with FITC-MSNs.  In experiment (b) HeLa cells were stained with the cell tracer dye and 
HUVECs were incubated with FITC-MSNs. The vertical axis corresponds to the intensity 
of green fluorescence due to uptake of FITC-MSNs and the horizontal axis to the 
intensity of red fluorescence due to dye-labeled cells.  Area Q1 corresponds to FITC-
fluorescent cells, Q4 to red-labeled cells, Q2 to cells giving both fluorescence signals. 
Left plots correspond to the cells exposed only to FITC-MSNs, center plots to the red-
labeled cells, and the plots to the right to the co-incubated cells (cross-cell experiment).  
The small proportion of Q2 cells in (a) compared to the large one in (b) suggests an 
asymmetric nature in the transfer of MSNs between both cell types. 
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Figure 5. Intracellular protein sequestration by magnetic-MSNs. Transmission electron 
micrographs of large pored MSNs with superparamagnetic iron oxide nanoparticles 
embedded in the mesopores.  Appearance of the particles before addition (a) and after 
recovery (b) from the cells.  Particle deterioration as well as presence of lower contrast 
bulks of material suggest capture of organics by the MSNs. (c) Relative amounts of 
organic species adsorbed to MSNs that were recovered from cell culture, as determined 
by thermogravimetric analysis. (d) Sodium dodecylsulfate polyacrilamide gel 
electrophoresis of the extract from the recovered magnetic-MSNs.  The first (left) lane is 
the ladder of molecular weight markers, all the other lanes correspond to the extract from 
MSNs.  The bands indicated by the arrows correspond to the proteins sequestered by the 
particles, the numbers correspond to the entries in Table 1. 
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Table 1. Proteins extracted from exocytosed MSNs.  The extracted proteins were 
subjected to MS/MS analysis and the resulting fingerprint spectra were compared to 
protein databases using Mascot software.  Matches with Mowse scores higher than 41 are 
expected to be identical or highly homologous (p<0.05) to the corresponding proteins. 
Band MW pI Protein UniProt Accesion Number Mowse Score 
2 39 7.6 Annexin A2 P07355  55 
3 42 5.3 Cytoplasmic actin-1 P60709 290 
4 105 5.3 -Actinin-4 O43707 120 
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